Agilent Technologies, Inc. (NYSE:A) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 2.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 49,218 shares of the medical research company’s stock after selling 1,088 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Agilent Technologies were worth $6,612,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. Flynn Zito Capital Management LLC grew its holdings in Agilent Technologies by 3.8% in the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock worth $251,000 after buying an additional 69 shares in the last quarter. IFP Advisors Inc boosted its position in Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock worth $62,000 after acquiring an additional 69 shares during the period. Brown Brothers Harriman & Co. grew its stake in shares of Agilent Technologies by 13.5% in the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after purchasing an additional 77 shares in the last quarter. Rothschild Investment LLC increased its holdings in shares of Agilent Technologies by 19.2% during the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after purchasing an additional 79 shares during the period. Finally, Rovin Capital UT ADV raised its stake in shares of Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares in the last quarter.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent analyst reports. Citigroup increased their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Sanford C. Bernstein decreased their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Bank of America dropped their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Robert W. Baird lowered their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday, February 27th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $146.15.

Agilent Technologies Trading Down 1.2 %

Shares of NYSE A opened at $126.36 on Tuesday. The business has a fifty day simple moving average of $140.48 and a 200-day simple moving average of $139.08. The company has a market cap of $36.05 billion, a price-to-earnings ratio of 29.05, a P/E/G ratio of 3.59 and a beta of 1.11. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.